Dividend Channel


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
ABBV Dividend History & Description — AbbVie Inc

AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and The Juvederm Collection of Fillers; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon and Synthroid. When considering the AbbVie Inc stock dividend history, we have taken known splits into account, such that the ABBV dividend history is presented on a split-adjusted ("apples to apples") basis. AbbVie Inc dividend history is presented both in graphical/chart form, and as a ABBV dividend history data table along the right-hand column.

Name:  AbbVie Inc
Stock buyback:  ABBV buyback
Website:  www.abbvie.com
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding ABBV:  131 (see which ones)
Total Market Value Held by ETFs:  $42,138,192,063.72
Total Market Capitalization:  $316,367,000,000
% of Market Cap. Held by ETFs:  13.32%

ABBV Stock Dividend History

The ABBV dividend history graphic shown above is presented after taking into consideration any known stock split occurrences, in order to present the most directly comparable ABBV historical dividend comparison possible. Historical dividends, when charted graphically, can reveal the long-term variability and/or growth within the ABBV dividend history record. Also see the ABBV stock dividend history data table along the right-hand column below.
Warren Buffett Dividend Stocks
Best Dividend Stocks 2004-2024
Dividend Growth Stocks: 25 Aristocrats
Future Dividend Aristocrats: Close Contenders
The Top 10 DividendRank'ed Stocks
Decades of Increasing Payments: 25 S.A.F.E. Dividend Stocks
Best High Dividend Stocks 2004-2024
The DividendRank Top 25
The Top 10 DividendRank'ed DJIA Components
Feel-Good Income: 25 Socially Responsible Dividend Stocks
Top Dividend Stocks 2014-2024
The Top 10 DividendRank'ed Dow Transports Components
The Top 10 DividendRank'ed Dow Utilities Components
The Top 10 DividendRank'ed Nasdaq 100 Components
Best High Yield Stocks 2014-2024
10 Stocks Going Ex-Dividend
10 Oversold Dividend Stocks
10 High Yield Baby Bonds
10 Stocks Where Yields Got More Juicy
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Top Ranked Dividend Stocks With Insider Buying
Top Dividend Stocks 2019-2024
Best Dividend Stocks Analysts Like in the S&P
Best Dividend Paying Stocks Analysts Like in the Dow
10 Cheap Dividend Stocks Under $10
10 Low Priced Dividend Stocks Under $5
Top High Dividend Yield Stocks 2019-2024
Broker Darlings: Top 15 Analyst Picks of the Dow
Top 25 Broker Analyst Picks of the S&P 500
Forgotten S&P 500 Giants: Analysts' Current Least Favorites
10 ETFs With Stocks That Insiders Are Buying
25 Dividend Giants Widely Held By ETFs
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
Cheap Energy Stocks Paying Dividends
Cheap Oil Stocks Paying Dividends
10 Metals Stocks You Can Buy Cheaper Than Insiders Did
10 Oversold Metals Stocks
10 Must-Know High-Yield REITs
10 Top DividendRank'ed Financials
10 Top DividendRank'ed Metals Stocks
10 Oversold Energy Stocks
10 Top DividendRank'ed Energy Stocks
10 Top DividendRank'ed Utility Stocks
10 Stocks Crossing Below Book Value
10 Stocks Crossing Above Their 200 Day Moving Average
10 Stocks Crossing Below Their 200 Day Moving Average
10 Dividend Stocks Crossing Above Their 200 DMA
10 Dividend Stocks Crossing Below Their 200 DMA
10 Top Covered Call ETFs
The 10 Biggest ETFs
The 10 Best ETF Performers
The 10 Worst ETF Performers
10 ETFs With Notable Inflows
10 ETFs With Notable Outflows
Top 10 Analyst Rated Consumer Stocks
Top 10 Analyst Rated Dividend Stocks
Top 10 Analyst Rated Energy Stocks
Warren Buffett Energy Stocks
Top 10 Analyst Rated Financial Stocks
Warren Buffett Bank Stocks
Top 10 Analyst Rated Healthcare Stocks
Top 10 Analyst Rated REIT Stocks
Top 10 Analyst Rated Technology Stocks
Warren Buffett Technology Stocks
The Top 10 DividendRank'ed Canadian Stocks
The DividendRank Canada Top 25
10 Canadian Stocks Going Ex-Dividend
10 Oversold Canadian Stocks
10 Canadian Stocks Where Yields Got More Juicy
10 Must-Know High-Yield Canadian Real Estate Stocks
10 Top DividendRank'ed Canadian Financials
10 Must-Know High-Yield Canadian Energy Stocks
10 Canadian Stocks Crossing Below Book Value
10 Canadian Stocks Crossing Above Their 200 Day Moving Avg
10 Canadian Stocks Crossing Below Their 200 Day Moving Avg
Stock market game
ABBV Next Earnings Date »
ABBV Next Dividend Date »
(Projection based upon history)
ABBV Dividend Growth Rate »
Quotes delayed 20 minutes
Email EnvelopeFree ABBV Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


Buy (3.18 out of 4)
43rd percentile
(ranked lower than approx. 57% of all stocks covered)

Analysts' Target Price:
ABBV Forecast

Based on data provided by Zacks Investment Research via Quandl.com
Projection:
ABBV Next Dividend Date
Chart:
ABBV Chart - 5Yr Dividend Yield

PARTNER NEWS:

Thu, Mar 28, 7:50 AM, Zacks
Pharma Stock Roundup: ABBV & NVO's New M&As, FDA Nod to JNJ & MRK PAH Drugs
While AbbVie (ABBV) is set to buy Landos Biopharma, Novo Nordisk (NVO) is set to acquire Cardior Pharmaceuticals. FDA approves J&J's (JNJ) and Merck's (MRK) PAH drugs.

Thu, Mar 28, 4:20 AM, Zacks
Should WisdomTree U.S. High Dividend ETF (DHS) Be on Your Investing Radar?
Style Box ETF report for DHS

ABBV | AbbVie Inc | Dividend History | Dividend Channel | www.DividendChannel.com | Copyright © 2010 - 2024, All Rights Reserved

Nothing in Dividend Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and dividend videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Dividend Channel; Meet Our Editorial Staff.